Uniting the leading minds in gene therapy at the Gene Therapy Durability Summit, join us to:

• Leverage knowledge from current clinical trials with relevant durability data across a range of indication types using AAV
• Better understand what can be extrapolated and how to gain confidence in the data collected
• Build study designs with durability in mind and explore how well preclinical models have predicted clinical durability to date

Hear from the likes of Pfizer, Selecta Biosciences, Spark Therapeutics, Rocket Pharmaceuticals, ASC Therapeutics and more across a preconference workshop day, expert presentations, interactive panel discussions, dedicated Q&A time and highly appraised networking opportunities to meet and learn from the leaders of this pioneering field.

When you attend you will:

• Understand the regulatory requirements to determine robust durability
• Explore the challenges short term immunogenicity has on durability
• Navigate how to overcome long term immunogenicity concerns on durability
• Optimize vectors constructs to maximize gene therapy durability
• Discover how to better predict the translational success of durability when progressing from preclinical to clinical trials

Register to attend with your colleagues and get up to 20% off your tickets – https://ter.li/oeczu3